Dr. Barron, Dr. Liang, Dr. Weber, and Dr. Josephson are members of the ACEP Public Health and Injury Prevention Committee.
Explore This Issue
ACEP Now: Vol 39 – No 01 – January 2020References
- Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2016. Atlanta: U.S. Department of Health and Human Services; 2017.
- LeFevre ML. Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(12):902-910.
- Papp JR, Schachter J, Gaydos CA, et al. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae. MMWR Recomm Rep. 2014;63(RR-02):1-19.
- Hobbs MM, van der Pol B, Totten P, et al. From the NIH: proceedings of a workshop on the importance of self-obtained vagina specimens for detection of sexually transmitted infections. Sex Transm Dis. 2008;35(1):8-13.
- Gaydos CA, Ferrero DV, Papp J. Laboratory aspects of screening men for Chlamydia trachomatis in the new millennium. Sex Transm Dis. 2008;35(11 suppl):S45-S50.
- Knox J, Tabrizi SN, Miller P, et al. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis. 2002;29(11):647-654.
- Cook RL, Hutchison SL, Østergaard L, et al. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med. 2005;142(11):914-925.
Pages: 1 2 | Single Page
No Responses to “Chlamydia and Gonorrhea Testing Best Practices”